2018
DOI: 10.1007/s11938-018-0190-2
|View full text |Cite
|
Sign up to set email alerts
|

Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives

Abstract: Purpose of reviewManagement of intraductal papillary mucinous neoplasm (IPMN) is currently based on consensus, in the absence of evidence-based guidelines. In recent years, several consensus guidelines have been published, with distinct management strategies. In this review, we will discuss these discrepancies, in order to guide treating physicians in clinical management.Recent findingsThe detection rate of pancreatic cysts has increased substantially with the expanded use of high-quality imaging techniques to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
63
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(64 citation statements)
references
References 120 publications
(170 reference statements)
1
63
0
Order By: Relevance
“…Some patients may present with abdominal discomfort, abdominal pain, malaise, and nausea; however, these symptoms are typically not attributable to the IPMN, even if they were the initial indication for abdominal imaging. 28 Other symptoms that include back pain, weight loss, NOD, and obstructive jaundice are more often associated with malignant transformation of an IPMN but, once again, are not entirely specific. [29][30][31][32]34,35,37,[46][47][48][49][50][51][52] Considering the lack of symptoms in most patients, conventional imaging modalities play a crucial role in the identification of IPMNs and IPMN-associated PDAC, as well as in the detection of a concomitant carcinoma.…”
Section: Diagnostic Methods Of Evaluating Bd-ipmn Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…Some patients may present with abdominal discomfort, abdominal pain, malaise, and nausea; however, these symptoms are typically not attributable to the IPMN, even if they were the initial indication for abdominal imaging. 28 Other symptoms that include back pain, weight loss, NOD, and obstructive jaundice are more often associated with malignant transformation of an IPMN but, once again, are not entirely specific. [29][30][31][32]34,35,37,[46][47][48][49][50][51][52] Considering the lack of symptoms in most patients, conventional imaging modalities play a crucial role in the identification of IPMNs and IPMN-associated PDAC, as well as in the detection of a concomitant carcinoma.…”
Section: Diagnostic Methods Of Evaluating Bd-ipmn Patientsmentioning
confidence: 99%
“…27 Because approximately half of all pancreatic cysts are BD-IPMNs, advanced age is a well-recognized risk factor for both BD-IPMNs and BD-IPMN-associated PDAC. 28 In addition to non-IPMN associated PDAC, a causative link between diabetes and IPMNs has been described. Among BD-IPMN patients, 10%-45% have a history of diabetes and, in the setting of diabetes, the incidence of detecting a BD-IPMN is higher.…”
Section: Epidemiologic Risk Factors For Cystic Precursor Lesionsmentioning
confidence: 99%
“…IPMN can complicate with acute pancreatitis (AP) [ 3 , 4 ], duct perforation, fistula formation into the adjacent lumen organs (the duodenum, common bile duct, stomach, colon and small intestine) [ 5 , 6 ] and spleen solid organ [ 7 ], intraductal bleeding or a massive abdominal cavity hematoma caused by rupture [ 1 , 2 ], and cyst infection [ 8 ], according to previous studies. AP is the most common complications of IPMN, approximately 20% of IPMN complicated with acute pancreatitis of mild to moderate severity [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Road, Gulou District, Fuzhou, China. 3 Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.…”
Section: Fundingmentioning
confidence: 99%
“…Total pancreatectomy is only indicated in selected cases and after carefully weighing the consequences against the potential benefits [12,14]. The overall recurrence rate of IPMN after resection is significant (up to 65%), and therefore lifelong surveillance is recommended by most guidelines and the intensity of follow-up is guided by the grade of dysplasia [12,14,15,132]. Risk factors for recurrence or progression include advanced dysplasia, multifocal disease, increased age, elevated BMI, and a positive family history for pancreatic cancer [133,134].…”
Section: Surgery and Surveillance After Resectionmentioning
confidence: 99%